selected publications
- De novo antiphospholipid antibody syndrome in two infants. Pediatric blood & cancer. 2022 Letter GET IT
-
EAHP 2020 workshop proceedings, pediatric myeloid neoplasms.
Virchows Archiv : an international journal of pathology.
2022
Conference Paper
GET IT
Times cited: 1 -
Clinical features associated with thrombotic events in children with myeloproliferative neoplasms.
American journal of hematology.
2022
Letter
GET IT
Times cited: 1 - Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies. Hematological oncology. 2022 Review GET IT
-
Familial thrombocythaemia - a distinct entity from essential thrombocythaemia.
British journal of haematology.
2021
Comment
GET IT
Times cited: 1 -
Health and Financial Burdens Associated With Venous Thrombosis in Hospitalized Children With Inflammatory Bowel Disease.
Journal of pediatric gastroenterology and nutrition.
2021
Academic Article
GET IT
Times cited: 4 -
Polycythemia vera in a 2-year-old child with a JAK2 exon 12 deletion.
Pediatric blood & cancer.
2021
Letter
GET IT
Times cited: 2 -
Assessment of provider practices regarding venous thromboembolism management and prevention in pediatric acute leukemia patients.
Journal of thrombosis and thrombolysis.
2021
Academic Article
GET IT
Times cited: 3 -
Use of pegylated interferon in young patients with polycythemia vera and essential thrombocythemia.
Pediatric blood & cancer.
2020
Academic Article
GET IT
Times cited: 5 -
Myeloproliferative Neoplasms in Children, Adolescents, and Young Adults.
Current hematologic malignancy reports.
2020
Review
GET IT
Times cited: 9 -
Children and Adolescents with Chronic Myeloproliferative Neoplasms: Still an Unmet Biological and Clinical Need?.
HemaSphere.
2019
Editorial Article
GET IT
Times cited: 1 -
Emerging translational science discoveries, clonal approaches, and treatment trends in chronic myeloproliferative neoplasms.
Hematological oncology.
2019
Review
GET IT
Times cited: 7 -
Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F-positive myeloproliferative neoplasms.
British journal of haematology.
2018
Letter
GET IT
Times cited: 9 -
Pediatric Gastroenterologists' Approach to Venous Thromboembolism Prophylaxis in Pediatric Inflammatory Bowel Disease.
Journal of pediatric gastroenterology and nutrition.
2018
Academic Article
GET IT
Times cited: 16 -
Genetic analysis of five children with essential thrombocytosis identified mutations in cancer-associated genes with roles in transcriptional regulation.
Haematologica.
2016
Letter
GET IT
Times cited: 13 -
Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias.
Blood.
2015
Academic Article
GET IT
Times cited: 29 - Transfusion medicine illustrated. Hemoglobin C after a red blood cell transfusion for sickle cell disease. 2015 GET IT
-
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.
Journal of thrombosis and haemostasis : JTH.
2015
Academic Article
GET IT
Times cited: 54 -
Primary thrombocytosis in children.
Haematologica.
2014
Review
GET IT
Times cited: 37 -
Thrombophilia in patients with retinoblastoma receiving ophthalmic artery chemosurgery.
2012
GET IT
Times cited: 5 -
JAK Inhibitors and other Novel Agents in Myeloproliferative Neoplasms: Are We Hitting the Target?.
Therapeutic advances in hematology.
2011
Academic Article
GET IT
Times cited: 2 -
The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia.
Cancer cell.
2010
Academic Article
GET IT
Times cited: 224 -
Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis.
Blood.
2010
Academic Article
GET IT
Times cited: 64